CDHF is Canada’s trusted source for timely information on the BC Biosimilars Initiative: Phase Two What is Changing? BC PharmaCare coverage is changing for people who […]

Helping inflammatory bowel disease (IBD) patients best understand transitioning/switching from a reference biologic to a biosimilar.

If you have recently been diagnosed with Inflammatory Bowel Disease (IBD) – Crohn’s disease or ulcerative colitis, you are likely to set sail on a journey […]